Review

Organ Dysfunction Following Trauma, Shock and Sepsis: An Update

Yu-Ren Wang , Hsin-I Tsai , Huang-Ping Yu
Department of Anesthesiology, Chang Gung Memorial Hospital, Taiwan, China
J Anesth Perioper Med 2015; 2(1): 36- 44 . Published on Jan 26, 2015 . doi:10.24015/JAPM.2015.0006
Abstract
Article
Figures & Tables
References
Author & Article info
PDF

Abstract

Aim of review: Trauma, shock and sepsis are often associated with multiple organ failure. Despite the progress made in patient management over the last decade, sepsis and subsequent multiple organ failure continue to be the major cause of morbidity and mortality in injured patients. 

Method: we review the current information on the multiple organ dysfunction and use of therapeutic apheresis procedures as adjunctive therapy in such clinical situations as well as the exciting prospects for the near future.

Recent findings: Most of clinical trials have failed to demonstrate any outcome benefit. However, corticosteroids, anti-endotoxin antibodies, anti-tumor necrosis factor-α antibody, interleukin (IL)-1β receptor antagonist and recombinant activated protein C are to date the possible drugs that may demonstrate mortality benefits in large randomized controlled trials. This could be attributed to their broad based attempts at modulating the inflammatory response to infection.

Summary: Basic research with related pathophysiologic approaches has driven clinical trials using molecules that might interfere with inflammatory processes. Against inflammatory response, the time to initiate therapy is thought to be crucial and the major determinant factor in surviving trauma, shock and sepsis. Despite substantial progress in trauma, shock and sepsis therapy, the important strategies between the discovery of new effective medical molecules and their implementation in the daily clinical practice of the intensive care unit remain a major hurdle. Fortunately, ongoing research continues to provide new information on the management of trauma, shock and sepsis. On this basis, new therapies could be tested to reduce mortality rates in trauma, shock and sepsis with respect to recently published studies.

 

 

Citation: Yu-Ren Wang, Hsin-I Tsai, Huang-Ping Yu. Organ dysfunction following trauma, shock and sepsis: an update. J Anesth Perioper Med 2015; 2: 36-44. doi: 10.24015/JAPM.2015.0006
 
This is an open-access article, published by Evidence Based Communications (EBC). This work is licensed under the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium or format for any lawful purpose. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Copyright © 2014-2017 | Evidence Based Communications (EBC)   All Rights Reserved.
Privacy Policy | Terms of Use | NIH Public Access Policy
ISSN: 2306-773X (Print) and 2520-3002 (Online)Submit a Manuscript | EBC and EBC Journals

The content on this site is intended for health professionals.
Loading